Avascular Necrosis of Bone in Leukemia and Osteonecrosis of Jaw by Bisphosphonates
- 1 December 2009
- journal article
- other
- Published by Elsevier in Journal of Oral and Maxillofacial Surgery
- Vol. 67 (12) , 2701-2703
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Patients with bisphosphonates‐associated osteonecrosis of the jaw have reduced circulating endothelial cellsHematological Oncology, 2007
- Patients with bisphosphonate-associated osteonecrosis of the jaw have unmodified levels of soluble vascular endothelial growth factor receptor 1Leukemia & Lymphoma, 2007
- Bisphosphonate-Associated Osteonecrosis of the Jaw in Patients with Multiple Myeloma and Breast CancerActa Haematologica, 2006
- Vascular endothelial growth factor (VEGF) gene transfer enhances surgical revascularization of necrotic boneJournal of Orthopaedic Research, 2005
- Pharmacogenetic Risk Factors for Osteonecrosis of the Hip Among Children With LeukemiaJournal of Clinical Oncology, 2004
- Treatment of Osteonecrosis of the Femoral Head with Implantation of Autologous Bone-Marrow CellsJournal of Bone and Joint Surgery, 2004
- Treatment of Osteonecrosis With Autologous Bone Marrow GraftingClinical Orthopaedics and Related Research, 2002
- Bony Morbidity in Children Treated for Acute Lymphoblastic LeukemiaJournal of Clinical Oncology, 2001
- Magnetic resonance imaging detection of avascular necrosis of the bone in children receiving intensive prednisone therapy for acute lymphoblastic leukemia or non-Hodgkin lymphomaLeukemia, 2001